Clinical Trials
3 trialsNCT00942877 2025-03-03
Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01337401 2019-01-24
CASPS
Institute of Cancer Research, United Kingdom
Phase 2 Unknown
NCT00385203 2012-07-16
The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).
AstraZeneca
Phase 2 Completed